Genotyping of -374A/T, -429A/G, and 63 bp INS/DEL polymorphisms of rage by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients

Nucleosides, Nucleotides and Nucleic Acids

Volumn 31, Issue 5, 2012, Pages 401-410

  Hashemi, Mohammad ^a,b   Moazeni roodi, Abdolkarim ^c   Arbabi, Farshid ^b   Fazaeli, Aliakbar ^b   Nasab, Ebrahim Eskandari ^b   Taheri, Mohsen ^a   Kerkhoff, Claus ^d   Ghavami, Saeid ^e  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Division of Gastroenterology   (Germany)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Polymorphism; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEXAPRIMER AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION; HUMAN; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPING TECHNIQUES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INDEL MUTATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 84859788252     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2012.665545     Document Type: Article

References (28)

1. Neeper, M.; Schmidt, A.M.; Brett, J.; Yan, S.D.; Wang, F.; Pan, Y.C.; Elliston, K.; Stern, D.; Shaw, A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267(21), 14998-15004.
2. Srikrishna, G.; Huttunen, H.J.; Johansson, L.; Weigle, B.; Yamaguchi, Y.; Rauvala, H.; Freeze, H.H. N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 2002, 80(6), 998-1008.
3. Ghavami, S.; Rashedi, I.; Dattilo, B.M.; Eshraghi, M.; Chazin, W.J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C.; Los,M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 2008, 83(6), 1484-1492.
4. Ghavami, S.; Kerkhoff, C.; Chazin, W.J.; Kadkhoda, K.; Xiao, W.; Zuse, A.; Hashemi, M.; Eshraghi, M.; Schulze-Osthoff, K.; Klonisch, T.; Los, M. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta 2008, 1783(2), 297-311.
5. Hudson, B.I.; Kalea, A.Z.; Del Mar Arriero, M.; Harja, E.; Boulanger, E.; D'Agati, V.; Schmidt, A.M. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 2008, 283(49), 34457-34468.
6. Schmidt, A.M.; Vianna, M.; Gerlach, M.; Brett, J.; Ryan, J.; Kao, J.; Esposito, C.; Hegarty, H.; Hurley, W.; Clauss, M.; Wang, F.; Pan, Y.E.; Tsang, T.C.; Stern, D. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 1992, 267(21), 14987-14997.
7. Hori, O.; Yan, S.D.; Ogawa, S.; Kuwabara, K.; Matsumoto, M.; Stern, D.; Schmidt, A.M. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol. Dial. Transplant. 1996, 11(Suppl. 5), 13-16.
8. Hofmann, M.A.; Drury, S.; Fu, C.; Qu, W.; Taguchi, A.; Lu, Y.; Avila, C.; Kambham, N.; Bierhaus, A.; Nawroth, P.; Neurath, M.F.; Slattery, T.; Beach, D.; McClary, J.; Nagashima, M.; Morser, J.; Stern, D.; Schmidt, A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97(7), 889-901.
9. Yan, S.F.; Barile, G.R.; D'Agati, V.; Du Yan, S.; Ramasamy, R.; Schmidt, A.M. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr. Diab. Rep. 2007, 7(2), 146-153.
10. Taguchi, A.; Blood, D.C.; del Toro, G.; Canet, A.; Lee, D.C.; Qu, W.; Tanji, N.; Lu, Y.; Lalla, E.; Fu, C.; Hofmann, M.A.; Kislinger, T.; Ingram, M.; Lu, A.; Tanaka, H.; Hori, O.; Ogawa, S.; Stern, D.M.; Schmidt, A.M. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405(6784), 354-360.
11. Yan, S.D.; Schmidt, A.M.; Anderson, G.M.; Zhang, J.; Brett, J.; Zou, Y.S.; Pinsky, D.; Stern, D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994, 269(13), 9889-9897.
12. Lander,H.M.; Tauras, J.M.; Ogiste, J.S.; Hori,O.; Moss, R.A.; Schmidt, A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependentmitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 1997, 272(28), 17810-17814.
13. Ghavami, S.; Chitayat, S.; Hashemi, M.; Eshraghi, M.; Chazin, W.J.; Halayko, A.J.; Kerkhoff, C. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol. 2009, 625(1-3), 73-83.
14. Bierhaus, A.; Stern, D.M.; Nawroth, P.P. RAGE in inflammation: a new therapeutic target? Curr. Opin. Investig. Drugs 2006, 7(11), 985-991.
15. Hsieh, H.L.; Schafer, B.W.; Sasaki, N.; Heizmann, C.W. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun. 2003, 307(2), 375-381.
16. Hudson, B.I.; Stickland, M.H.; Futers, T.S.; Grant, P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50(6), 1505-1511.
17. Hashemi, M.; Moazeni-Roodi, A.K.; Fazaeli, A.; Sandoughi, M.; Bardestani, G.R.; Kordi-Tamandani, D.M.; Ghavami, S. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet Mol. Res. 2010, 9(1), 333-339.
18. Hashemi, M.; Moazeni-Roodi, A.; Bahari, A.; Taheri, M. A tetra-primer amplification refractory mutation system polymerase chain reaction for the detection of rs8099917 IL28B genotype. Nucleosides Nucleotides Nucleic Acids 2012, 31(1), 55-60.
19. Wautier, J.L.; Zoukourian, C.; Chappey, O.;Wautier, M.P.; Guillausseau, P.J.; Cao, R.;Hori, O.; Stern, D.; Schmidt, A.M. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 1996, 97(1), 238-243.
20. Meloche, J.; Paulin, R.; Courboulin, A.; Lambert, C.; Barrier, M.; Bonnet, P.; Bisserier, M.; Roy, M.; Sussman, M.A.; Agharazii, M.; Bonnet, S. RAGE-dependent activation of the oncoprotein pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler. Thromb. Vasc. Biol. 2011, 31(9), 2114-2124.
21. Ichikawa, M.; Williams, R.; Wang, L.; Vogl, T.; Srikrishna, G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 2011, 9(2), 133-148.
22. Bierhaus, A.; Humpert, P.M.; Morcos, M.; Wendt, T.; Chavakis, T.; Arnold, B.; Stern, D.M.; Nawroth, P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83(11), 876-886.
23. Hofmann, M.A.; Drury, S.;Hudson, B.I.; Gleason, M.R.; Qu,W.; Lu, Y.; Lalla, E.; Chitnis, S.;Monteiro, J.; Stickland, M.H.; Bucciarelli, L.G.; Moser, B.; Moxley, G.; Itescu, S.; Grant, P.J.; Gregersen, P.K.; Stern, D.M.; Schmidt, A.M. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002, 3(3), 123-135.
24. Falcone, C.; Emanuele, E.; D'Angelo, A.; Buzzi, M.P.; Belvito, C.; Cuccia, M.; Geroldi, D. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 2005, 25(5), 1032-1037.
25. Gu, H.; Yang, L.; Sun, Q.; Zhou, B.; Tang, N.; Cong, R.; Zeng, Y.; Wang, B. Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. Clin. Cancer Res. 2008, 14(11), 3627-3632.
26. Vasku, V.; Kankova, K.; Vasku, A.; Muzik, J.; Izakovicova Holla, L.; Semradova, V.; Vacha, J. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis. Arch. Dermatol. Res. 2002, 294(3), 127-130.
27. Tesarova, P.; Kalousova, M.; Jachymova, M.; Mestek, O.; Petruzelka, L.; Zima, T. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Investigation 2007, 25(8), 720-725.
28. Schenk, S.; Schraml, P.; Bendik, I.; Ludwig, C.U. A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer. Lung Cancer 2001, 32(1), 7-12.